Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02495142
Other study ID # 5R01DK084979-06
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2010
Est. completion date June 30, 2019

Study information

Verified date August 2019
Source Neuropsychiatric Research Institute, Fargo, North Dakota
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Bariatric surgery is associated with long-term weight loss, as well as short-term improvements in obesity-related medical comorbidities. However, a significant proportion of patients fail to lose sufficient weight, or experience significant weight regain. Although no robust predictors of response have been identified, pilot data that will be presented and reviewed suggest that surgery has profound effects on eating behaviors and psychosocial functioning, and that these factors may affect postoperative weight control.

The present investigation capitalizes on the Longitudinal Assessment of Bariatric Surgery (LABS) consortium to conduct an in-depth examination of the psychosocial aspects of surgery among a geographically, ethnically, and racially diverse sample of men and women undergoing bariatric surgery. This project unites experts in the areas of psychopathology, eating behaviors and quality of life to conduct a naturalistic study using state-of-the-art assessment tools; to document the relationships among psychosocial factors; and to examine psychosocial predictors of surgical outcomes.


Description:

Primary Objective. Despite the obvious impact of bariatric surgery procedures on intake, no study to date has included a careful assessment of psychological factors, feeding patterns, energy intake and eating problems in this group of patients longitudinally. The Investigators believe that a careful examination of the structure of eating behavior and eating problems (e.g. vomiting) would be very helpful in guiding bariatric surgeons and dieticians who work with this group of patients in terms of dietary advice and recommendations, and with the prediction of eating problems and poor nutrient intake in the subgroup that develops such problems. This study involves prospective assessment of psychosocial outcomes of surgery by adding a supplemental battery to the LABS-2 assessment schedule. Conducting assessments at three of the LABS clinical sites assures the geographic, ethnic, and racial diversity of the sample, and hence enhances the potential to identify a subgroup or subgroups of patients susceptible to poor outcomes after surgery and the generalizability of study results.

This study would also include an evaluation of psychopathological and behavioral variables that might impact on weight loss and weight regain, and psychosocial complications post-operatively, as well as quality of life.

The overall goal of this study is to obtain detailed information that will allow a careful assessment of psychopathology, quality of life and eating behavior pre-surgically and at regular intervals for up to 7 years after the surgical intervention.

The Investigators believe that the instruments and procedures selected will allow a detailed examination of psychopathology, eating pathology and quality of life in detail.

The Investigators believe that the measures and tasks added at year 7 will allow the examination of theories of affect regulation, cognitive control, and reward processing in understanding postsurgical outcomes regarding pathological eating behavior and alcohol/substance use and their shared similarities as well as underlying neurobiological systems.


Other known NCT identifiers
  • NCT00582595

Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male and female patients who are at least 18 years of age and undergo bariatric surgery by a LABS certified surgeon.

- Previous enrollment in LABS-1 and LABS-2.

- BMI at baseline of greater than or equal to 35.

Exclusion Criteria:

- Informed consent not obtained

- Type 1 Diabetes Mellitus

- Unlikely to comply with follow-up protocol (ie: geographically inaccessible for study visits)

- Unable to communicate with local study staff

Study Design


Locations

Country Name City State
United States Neuropsychiatric Research Institute Fargo North Dakota

Sponsors (4)

Lead Sponsor Collaborator
Neuropsychiatric Research Institute, Fargo, North Dakota Columbia University, Duquesne University, University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Affect regulation as measured by the DERS Difficulties in Emotion Regulation Scale: The DERS is a 36-item self-report questionnaire that assesses six domains of emotion dysregulation and has been found to have acceptable internal consistency as well as adequate test-retest reliability and construct validity. 7 year post bariatric surgery
Other Affect regulation as measured by the AIM Affect Intensity Measure:The AIM is a 40-item self-report measure of positive and negative emotional intensity and reactivity. 7 years post bariatric surgery
Other Impulsivity UPPS-P Impulsive Behavior Scale: This is a 59-item self-report measure assessing five dimensions of impulsivity. Only the negative urgency and positive urgency subscales will be administered. 7 years post bariatric surgery
Other Behavioral inhibition as measured by the SPSRQ Sensitivity to Punishment and Sensitivity to Reward Questionnaire: This is a 44-item self-report measure that is based on Gray's behavioral inhibition and activation motivational systems conceptualization, and assesses sensitivity to punishment and reward. 7 years post bariatric surgery
Other Temperament as measured by the ATQ Effortful Control Scale of the Adult Temperament Questionnaire: This 19-item self-report measure assesses several components of dispositional effortful control, including attentional control (i.e., ability to voluntarily focus or shift attention), inhibitory control (i.e., ability to inhibit behavior), and activation control (i.e., ability to activate behavior as needed). 7 years post bariatric surgery
Other Cognitive Control as measured by the Go/No-Go Task Go/No-Go Task: This computerized task assesses the capacity for suppressing previously reinforced responses. 7 years post bariatric surgery
Other Cognitive Control as measured by the Delay Discounting Task Delay Discounting Task: Delay discounting tasks require participants to choose between receiving a larger amount of money after a delay versus receiving a smaller amount immediately. 7 years post bariatric surgery
Primary Change in Psychopathology as measured by the SCID Structured Clinical Interview for DSM-IV, Patients Edition (SCID) will be administered to assess comorbid Axis I psychopathology. annually up to 7 years post bariatric surgery
Secondary Change in Quality of life as measured by the IWQOL Impact of Weight on Quality of Life Questionnaire: This is a 31-item, self-report, obesity-specific quality of life measure that will be utilized to assess quality of life. annually up to 7 years post bariatric surgery
Secondary Change in Quality of life as measured by the SF-36 ShortForm-36: The SF-36 is a 36-item questionnaire that assesses functioning and quality of life as it relates to health status. annually up to 7 years post bariatric surgery
Secondary Change in Depression as measured by the BDI Beck Depression Inventory: The BDI is a 21-item instrument that is widely used to assess depressive symptoms. annually up to 7 years post bariatric surgery
Secondary Change in Eating behaviors as measured by the EDE Eating Disorder Examination: The diagnostic version of the EDE will be used as the primary measure of eating behavior and pathology. annually up to 7 years post bariatric surgery
Secondary Change in Impulse Control as measured by the SCID-ICD module The impulse control module of the SCID will be administered to assess impulsive/compulsive disorders for participants. annually up to 7 years post bariatric surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2